Cowen Expects Revance Therapeutics (RVNC) Weakness to Reverse, Reiterates $55 Price Target
Tweet Send to a Friend
Cowen analyst Ken Cacciatore maintains Outperform on Revance Therapeutic (NASDAQ: RVNC) price target of $55.00.The analyst comments "Allergan this morning ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
